ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 82

Patients with Rheumatoid Arthritis in Germany: Are They Ready for Ehealth Via Mobile Medical Applications?

Jutta G. Richter1, Christina Kampling2, Gamal Chehab3, Hasan Acar2, Arnd Becker4 and Matthias Schneider5, 1Policlinic of Rheumatology and Hiller Research Unit Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany, 2Policlinic of Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany, 3Policlinic of Rheumatology, Heinrich-Heine-University, 40225 Duesseldorf, Germany, 4Ortenau Klinikum Offenburg-Gengenbach, Gengenbach, Gengenbach, Germany, 5Department of Rheumatology & Hiller Research Unit, Heinrich-Heine-University, Duesseldorf, Germany

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: online patient engagement, online resources and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Health Services Research - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Mobile medical Applications (mApps) with diary functions and integrated patient-reported outcome instruments allow patients (pts) with rheumatoid arthritis (RA) to self-monitor their disease apart from out-pts visits and thus might strengthen self-management. In a project evaluating the usability of a mApp with diary function we studied pts’ given information technology (IT) prerequisites, especially their hitherto use of Internet and apps on mobile devices.

Methods: Inclusion criteria were RA diagnosis, age of consent and German speaking. 268 consecutive RA out-pts were screened, 157 (58.6%) owned an App-compatible device, and 60 pts (38.2%) agreed to complete paper-based questionnaires assessing experiences and knowledge regarding IT aspects, App/internet use, and sociodemographic and clinical trial data. Ethic approval and pts’ signed informed consents were obtained. The identifier at clinicaltrials.gov is NCT02565225.

Results: Pts were predominantly female (78.3%), mean±SD age was 50.1±13.1 years (yrs), mean disease duration 10.5±9.1 yrs. 50% had a high education level. 93.3% reported substantial experience with a smartphone, 70.0% with a tablet. 80% wanted to use the project-App on their smartphone, 20% on their tablet. Pts were familiar with their devices for 3.0±2.4 yrs. Internet use via the device was reported for private (91.7%) and official business issues (30.0%). 43.3% confirmed Internet use via the device during business hours. It was accessed via the contract of their device by 66.7% (3G 37.5%; 4G 27.5%), via WIFI at home (81.7%) or in public areas (35.0%) for 2.3±2.9 hours/day. 90.0% already used Apps, these reported use of health (24.1%), diet (9.3%), games (37.0%), communication/social media networks (59.3%), news (59.3%), weather information (79.6%), music (33.3%), sport (20.4%) and productivity (24.1%) Apps. Most (94.4%) stated use of free-of-charge Apps, 44.4% of Apps with costs. Although being informed that the project mApp was not build to send data via the Internet 18.3% believed that data entered in the mApp will be stored in a cloud, 35.0% had no idea how the data is stored. 51.7% think they know the way an App works. Perceived data security on their App-compatible device was rated 3.0±1.4 (1(= high)–6(= low) Likert scale). 63.3% rated new media technology as predominantly beneficial for patient-physician interaction.

Conclusion: More than half of the pts owned App-compatible devices. Pts apply them for mobile Internet and App use even in business hours. Technical requirements for patient-physician communication via mobile devices are fulfilled in these pts, although IT literacy seems still to be narrowed in some pts. However, eHealth concepts via a mApp for monitoring disease apart from the physician visits seem feasible. Our project will deliver further important data of the mApp – a powerful tool at our fingertips.


Disclosure: J. G. Richter, None; C. Kampling, None; G. Chehab, None; H. Acar, None; A. Becker, None; M. Schneider, None.

To cite this abstract in AMA style:

Richter JG, Kampling C, Chehab G, Acar H, Becker A, Schneider M. Patients with Rheumatoid Arthritis in Germany: Are They Ready for Ehealth Via Mobile Medical Applications? [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/patients-with-rheumatoid-arthritis-in-germany-are-they-ready-for-ehealth-via-mobile-medical-applications/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-with-rheumatoid-arthritis-in-germany-are-they-ready-for-ehealth-via-mobile-medical-applications/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology